| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology and Pharmacology (Drs. Gwinn–Hardy, Singleton, Hardy, and Farrer, and A. Adam), Mayo Clinic Jacksonville, FL; Meharry Medical College (Dr. Chen), Nashville, TN; Massachusetts General Hospital (Dr. Koroshetz), Boston; Athena Corporation USA (Drs. Boss and Seltzer), Worcester, MA; University of Southern California (Dr. Waters), Los Angeles; and Veterans General Hospital (Drs. H.-C. Liu, T. Y. Liu), Taipei, Taiwan.
Address correspondence and reprint requests to Dr. Katrina Gwinn–Hardy, Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Rd., Jacksonville, FL 32224; e-mail: gwinn.katrina{at}mayo.edu
OBJECTIVE: To describe the clinical and molecular genetic analysis of a large family of northern Chinese descent with a mutation at the SCA2 locus causing carbidopa-levodopa–responsive parkinsonism.
BACKGROUND: Most causes of parkinsonism remain unknown. However, molecular genetic analysis of families with parkinsonism has recently identified five distinct loci and pathogenic mutations in four of those. Additionally, some of the spinocerebellar ataxia syndromes (SCA), particularly Machado–Joseph syndrome (SCA3), are known to cause parkinsonism. Spinocerebellar ataxia type 2 (SCA2) has not previously been described as causing a typical dopamine-responsive asymmetric PD phenotype.
METHODS: A large family was evaluated clinically and molecularly for apparent autosomal dominant parkinsonism.
RESULTS: The phenotype includes presentation consistent with typical dopamine-responsive parkinsonism. Other presentations in this family include a parkinsonism/ataxia phenotype, which is classic for SCA2 and parkinsonism, resembling progressive supranuclear palsy.
CONCLUSIONS: Patients presenting with a family history of parkinsonism, including familial progressive supranuclear palsy and PD, should be tested for the spinocerebellar ataxia type 2 expansion.
This article has been cited by other articles:
|
|
 |
|
  P. Charles, A. Camuzat, N. Benammar, F. Sellal, A. Destee, A-M Bonnet, S. Lesage, I. Le Ber, G. Stevanin, A. Durr, et al. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology, November 20, 2007; 69(21): 1970 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Kim, S. Hong, G. P. Kim, Y. J. Choi, Y. K. Kim, S. S. Park, S. E. Kim, and B. S. Jeon Importance of Low-Range CAG Expansion and CAA Interruption in SCA2 Parkinsonism Arch Neurol, October 1, 2007; 64(10): 1510 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S M Boesch, J Muller, G K Wenning, and W Poewe Cervical dystonia in spinocerebellar ataxia type 2: clinical and polymyographic findings J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 520 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Satterfield and L. J. Pallanck Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes Hum. Mol. Genet., August 15, 2006; 15(16): 2523 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Wullner, M. Reimold, M. Abele, K. Burk, M. Minnerop, B.-M. Dohmen, H.-J. Machulla, R. Bares, and T. Klockgether Dopamine Transporter Positron Emission Tomography in Spinocerebellar Ataxias Type 1, 2, 3, and 6 Arch Neurol, August 1, 2005; 62(8): 1280 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A.G. Teive, B. B. Roa, S. Raskin, P. Fang, W. O. Arruda, Y. C. Neto, R. Gao, L. C. Werneck, and T. Ashizawa Clinical phenotype of Brazilian families with spinocerebellar ataxia 10 Neurology, October 26, 2004; 63(8): 1509 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gwinn-Hardy When Is Ataxia Not Ataxia? Arch Neurol, January 1, 2004; 61(1): 25 - 26. [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Lu, Y.-H. Wu Chou, P.-C. Kuo, H.-C. Chang, and Y.-H. Weng The Parkinsonian Phenotype of Spinocerebellar Ataxia Type 2 Arch Neurol, January 1, 2004; 61(1): 35 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Furtado, M. Farrer, Y. Tsuboi, M. L. Klimek, R. de la Fuente-Fernandez, J. Hussey, P. Lockhart, D. B. Calne, O. Suchowersky, A. J. Stoessl, et al. SCA-2 presenting as parkinsonism in an Alberta family: Clinical, genetic, and PET findings Neurology, November 26, 2002; 59(10): 1625 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Racette, M. Rundle, J. C. Wang, A. Goate, N. L. Saccone, M. Farrer, S. Lincoln, J. Hussey, S. Smemo, J. Lin, et al. A multi-incident, Old-Order Amish family with PD Neurology, February 26, 2002; 58(4): 568 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Mouradian Recent advances in the genetics and pathogenesis of Parkinson disease Neurology, January 22, 2002; 58(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
